RTX Corp: Form 10-K for the period ended Dec 31, 2014
Filed with the SEC on Feb 5, 2015 and accepted by EDGAR at Feb 5, 2015, 11:57 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-10-01 to 2014-12-31 | $17.00bn | us-gaap:SalesRevenueNet |
| Revenue | 12 months2014-01-01 to 2014-12-31 | $65.10bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2014-01-01 to 2014-12-31 | $36.04bn | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2014-10-01 to 2014-12-31 | $4.64bn | us-gaap:GrossProfit |
| Research and development | 12 months2014-01-01 to 2014-12-31 | $2.63bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2014-01-01 to 2014-12-31 | $6.50bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2014-01-01 to 2014-12-31 | $9.77bn | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2014-01-01 to 2014-12-31 | $2.26bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-10-01 to 2014-12-31 | $1.47bn | us-gaap:NetIncomeLoss |
| Net income | 12 months2014-01-01 to 2014-12-31 | $6.22bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-10-01 to 2014-12-31 | $1.62 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2014-01-01 to 2014-12-31 | $6.82 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-10-01 to 2014-12-31 | $1.64 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2014-01-01 to 2014-12-31 | $6.92 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2014-01-01 to 2014-12-31 | 911,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2014-01-01 to 2014-12-31 | $7.34bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2014-01-01 to 2014-12-31 | $1.71bn | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 12 months2014-01-01 to 2014-12-31 | $2.05bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2014-01-01 to 2014-12-31 | $1.50bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2014-12-31 | $29.76bn | us-gaap:AssetsCurrent |
| Total assets | At period end2014-12-31 | $91.29bn | us-gaap:Assets |
| Current liabilities | At period end2014-12-31 | $22.89bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-12-31 | $58.59bn | us-gaap:Liabilities |
| Long-term debt | At period end2014-12-31 | $19.67bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2014-12-31 | $126.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2014-12-31 | $31.21bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000101829-15-000005. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.